New York State Common Retirement Fund’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Hold |
7,837
| – | – | ﹤0.01% | 2553 |
|
|
2025
Q1 | $87K | Hold |
7,837
| – | – | ﹤0.01% | 2579 |
|
|
2024
Q4 | $83K | Hold |
7,837
| – | – | ﹤0.01% | 2671 |
|
|
2024
Q3 | $100K | Sell |
7,837
-7,000
| -47% | -$89.3K | ﹤0.01% | 2588 |
|
|
2024
Q2 | $249K | Buy |
14,837
+5,914
| +66% | +$99.3K | ﹤0.01% | 2335 |
|
|
2024
Q1 | $134K | Buy |
8,923
+360
| +4% | +$5.41K | ﹤0.01% | 2626 |
|
|
2023
Q4 | $128K | Sell |
8,563
-37
| -0.4% | -$553 | ﹤0.01% | 2642 |
|
|
2023
Q3 | $120K | Buy |
8,600
+200
| +2% | +$2.79K | ﹤0.01% | 2634 |
|
|
2023
Q2 | $87K | Buy |
+8,400
| New | +$87K | ﹤0.01% | 2963 |
|
|
2022
Q3 | – | Sell |
-174
| Closed | -$1K | – | 3451 |
|
|
2022
Q2 | $1K | Sell |
174
-13,400
| -99% | -$77K | ﹤0.01% | 3415 |
|
|
2022
Q1 | $118K | Sell |
13,574
-18
| -0.1% | -$156 | ﹤0.01% | 2988 |
|
|
2021
Q4 | $129K | Sell |
13,592
-1,909
| -12% | -$18.1K | ﹤0.01% | 3015 |
|
|
2021
Q3 | $261K | Sell |
15,501
-3,157
| -17% | -$53.2K | ﹤0.01% | 2804 |
|
|
2021
Q2 | $285K | Sell |
18,658
-242
| -1% | -$3.7K | ﹤0.01% | 2878 |
|
|
2021
Q1 | $368K | Sell |
18,900
-1,000
| -5% | -$19.5K | ﹤0.01% | 2594 |
|
|
2020
Q4 | $359K | Hold |
19,900
| – | – | ﹤0.01% | 2509 |
|
|
2020
Q3 | $384K | Hold |
19,900
| – | – | ﹤0.01% | 2344 |
|
|
2020
Q2 | $520K | Buy |
19,900
+3,600
| +22% | +$94.1K | ﹤0.01% | 2179 |
|
|
2020
Q1 | $291K | Hold |
16,300
| – | – | ﹤0.01% | 2279 |
|
|
2019
Q4 | $544K | Sell |
16,300
-2,900
| -15% | -$96.8K | ﹤0.01% | 2258 |
|
|
2019
Q3 | $458K | Hold |
19,200
| – | – | ﹤0.01% | 2379 |
|
|
2019
Q2 | $690K | Buy |
+19,200
| New | +$690K | ﹤0.01% | 2212 |
|